Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
Fase III-studies naar gantenerumab bij vroege ziekte van Alzheimer
mrt 2024 | Dementie